The cost-effectiveness of tailored smoking cessation interventions for people with severe mental illness: a model-based economic evaluationResearch in context

Summary: Background: Tailored smoking cessation interventions, which combine behavioural and pharmaceutical support, are effective in populations with severe mental illness (SMI). We establish the cost-effectiveness of two tailored interventions in the UK: (i) a bespoke smoking cessation interventi...

Full description

Bibliographic Details
Main Authors: Richard Mattock, Lesley Owen, Matthew Taylor
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:EClinicalMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023000056
_version_ 1797860347552464896
author Richard Mattock
Lesley Owen
Matthew Taylor
author_facet Richard Mattock
Lesley Owen
Matthew Taylor
author_sort Richard Mattock
collection DOAJ
description Summary: Background: Tailored smoking cessation interventions, which combine behavioural and pharmaceutical support, are effective in populations with severe mental illness (SMI). We establish the cost-effectiveness of two tailored interventions in the UK: (i) a bespoke smoking cessation intervention (BSCI) versus usual care, and (ii) integrated tobacco cessation and mental health care (IC) versus standard smoking cessation clinic (SCC) referral. Methods: This economic evaluation was conducted between January 15th 2019 and August 4th 2022. We adapted a Markov model estimating smoking status, healthcare costs and quality-adjusted life years (QALYs) across the lifetime. Intervention effectiveness and costs were obtained from a systematic review and a meta-analysis. We obtained specific parameter values for populations with SMI for mortality, risk of smoking related comorbidities, and health utility. Uncertainty was analysed in deterministic and probabilistic sensitivity analysis (PSA). Findings: The BSCI was cost-effective versus usual care with an incremental cost-effectiveness ratio (ICER) of £3145 per QALY (incremental costs: £165; incremental QALYs: 0.05). Integrated care was cost-effective versus SCC with an ICER of £6875 per QALY (incremental costs: £292; incremental QALYs: 0.04). The BSCI and IC were cost-effective in 89% and 83% of PSA iterations respectively. The main area of uncertainty related to relapse rates. Interpretation: Our findings suggested that the tailored interventions were cost-effective and could increase QALYs and decrease expenditure on treating smoking related morbidities if offered to people with SMI. Funding: York Health Economics Consortium was funded by the National Institute for Health and Care Excellence to produce economic evaluations to inform public health guidelines.
first_indexed 2024-04-09T21:45:32Z
format Article
id doaj.art-5b63f28c4eef421c8e1fe8daf7d56f3b
institution Directory Open Access Journal
issn 2589-5370
language English
last_indexed 2024-04-09T21:45:32Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series EClinicalMedicine
spelling doaj.art-5b63f28c4eef421c8e1fe8daf7d56f3b2023-03-25T05:14:20ZengElsevierEClinicalMedicine2589-53702023-03-0157101828The cost-effectiveness of tailored smoking cessation interventions for people with severe mental illness: a model-based economic evaluationResearch in contextRichard Mattock0Lesley Owen1Matthew Taylor2Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK; York Health Economics Consortium, University of York, York, UK; Corresponding author. Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, LS2 9NL, UK.National Institute for Health and Care Excellence, London, UKYork Health Economics Consortium, University of York, York, UKSummary: Background: Tailored smoking cessation interventions, which combine behavioural and pharmaceutical support, are effective in populations with severe mental illness (SMI). We establish the cost-effectiveness of two tailored interventions in the UK: (i) a bespoke smoking cessation intervention (BSCI) versus usual care, and (ii) integrated tobacco cessation and mental health care (IC) versus standard smoking cessation clinic (SCC) referral. Methods: This economic evaluation was conducted between January 15th 2019 and August 4th 2022. We adapted a Markov model estimating smoking status, healthcare costs and quality-adjusted life years (QALYs) across the lifetime. Intervention effectiveness and costs were obtained from a systematic review and a meta-analysis. We obtained specific parameter values for populations with SMI for mortality, risk of smoking related comorbidities, and health utility. Uncertainty was analysed in deterministic and probabilistic sensitivity analysis (PSA). Findings: The BSCI was cost-effective versus usual care with an incremental cost-effectiveness ratio (ICER) of £3145 per QALY (incremental costs: £165; incremental QALYs: 0.05). Integrated care was cost-effective versus SCC with an ICER of £6875 per QALY (incremental costs: £292; incremental QALYs: 0.04). The BSCI and IC were cost-effective in 89% and 83% of PSA iterations respectively. The main area of uncertainty related to relapse rates. Interpretation: Our findings suggested that the tailored interventions were cost-effective and could increase QALYs and decrease expenditure on treating smoking related morbidities if offered to people with SMI. Funding: York Health Economics Consortium was funded by the National Institute for Health and Care Excellence to produce economic evaluations to inform public health guidelines.http://www.sciencedirect.com/science/article/pii/S2589537023000056Cost-effectivenessTobaccoCessationSmokingSevere mental illness
spellingShingle Richard Mattock
Lesley Owen
Matthew Taylor
The cost-effectiveness of tailored smoking cessation interventions for people with severe mental illness: a model-based economic evaluationResearch in context
EClinicalMedicine
Cost-effectiveness
Tobacco
Cessation
Smoking
Severe mental illness
title The cost-effectiveness of tailored smoking cessation interventions for people with severe mental illness: a model-based economic evaluationResearch in context
title_full The cost-effectiveness of tailored smoking cessation interventions for people with severe mental illness: a model-based economic evaluationResearch in context
title_fullStr The cost-effectiveness of tailored smoking cessation interventions for people with severe mental illness: a model-based economic evaluationResearch in context
title_full_unstemmed The cost-effectiveness of tailored smoking cessation interventions for people with severe mental illness: a model-based economic evaluationResearch in context
title_short The cost-effectiveness of tailored smoking cessation interventions for people with severe mental illness: a model-based economic evaluationResearch in context
title_sort cost effectiveness of tailored smoking cessation interventions for people with severe mental illness a model based economic evaluationresearch in context
topic Cost-effectiveness
Tobacco
Cessation
Smoking
Severe mental illness
url http://www.sciencedirect.com/science/article/pii/S2589537023000056
work_keys_str_mv AT richardmattock thecosteffectivenessoftailoredsmokingcessationinterventionsforpeoplewithseverementalillnessamodelbasedeconomicevaluationresearchincontext
AT lesleyowen thecosteffectivenessoftailoredsmokingcessationinterventionsforpeoplewithseverementalillnessamodelbasedeconomicevaluationresearchincontext
AT matthewtaylor thecosteffectivenessoftailoredsmokingcessationinterventionsforpeoplewithseverementalillnessamodelbasedeconomicevaluationresearchincontext
AT richardmattock costeffectivenessoftailoredsmokingcessationinterventionsforpeoplewithseverementalillnessamodelbasedeconomicevaluationresearchincontext
AT lesleyowen costeffectivenessoftailoredsmokingcessationinterventionsforpeoplewithseverementalillnessamodelbasedeconomicevaluationresearchincontext
AT matthewtaylor costeffectivenessoftailoredsmokingcessationinterventionsforpeoplewithseverementalillnessamodelbasedeconomicevaluationresearchincontext